图书馆主页
数据库简介
最新动态
联系我们



返回首页


 刊名字顺( Alphabetical List of Journals):

  A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL


  检 索:         高级检索

期刊名称:DNA REPAIR

ISSN:1568-7864
版本:SCI-CDE
出版频率:Monthly
出版社:ELSEVIER, RADARWEG 29, AMSTERDAM, NETHERLANDS, 1043 NX
  出版社网址:http://www.elsevier.com/wps/find/homepage.cws_home
期刊网址:http://www.journals.elsevier.com/dna-repair/
影响因子:4.913
主题范畴:GENETICS & HEREDITY;    TOXICOLOGY

期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)   



About the journal

DNA REPAIR

(Formerly: Mutation Research - DNA Repair)

 provides a forum for the comprehensive coverage of cellular responses to DNA damage in living cells.
The journal publishes original observations on genetic, cellular, biochemical and molecular aspects of DNA repair, mutagenesis, cell cycle regulation, apoptosis and other biological responses to cells exposed to genomic insult, as well as their relationship to human diseases.
Original full-length papers are published monthly. In addition, the journal will publish a smaller number of peer-reviewed Brief Reports on original research findings of special interest, as well as invited Mini-reviews on selected topics that provide 'state-of-the-art' synopses of cellular responses to DNA damage. Book reviews and meeting reports will be regularly featured and the Journal welcomes Correspondence from the scientific community, especially as they relate to papers previously published in the journal. These are handled directly by the Editor-in-Chief and may be accompanied by responses solicited from relevant individuals.


Instructions to Authors

All articles should be submitted with four copies (one original and three copies, and four sets of original illustrations) to one of the Receiving Editors (see below for addresses).

TYPES OF ARTICLES
DNA REPAIR provides a forum for the comprehensive coverage of cellular responses to DNA damage in living cells.
The journal publishes original observations on genetic, cellular, biochemical and molecular aspects of DNA repair, mutagenesis, cell cycle regulation, apoptosis and other biological responses to cells exposed to genomic insult, as well as their relationship to human diseases. Original full-length papers are published monthly. In addition, the journal will publish a smaller number of peer-reviewed Brief Reports on original research findings of special interest, as well as invited Mini-reviews on selected topics that provide 'state-of-the-art' synopses of cellular responses to DNA damage. Book reviews and meeting reports will be regularly featured and the Journal welcomes Correspondence from the scientific community, especially as they relate to papers previously published in the journal. These are handled directly by the Editor-in-Chief and may be accompanied by responses solicited from relevant individuals.

General arrangement of papers Papers should be in English, typewritten, and double-spaced. Final versions should be accompanied by a diskette (see `Electronic manuscripts' below). They should include key words (3-6 words or short phrases) and an abstract of up to 300 words. The Introduction should summarise the research problem and the pertinent findings. The text may be divided into sections such as Materials and methods, Results, Discussion, etc. All main sections should be numbered. In papers mentioning chemicals, authors are requested to include CAS registry numbers.
Preparation of text Each manuscript should have a separate title page which includes only the title, authors' full names and complete addresses of academic or professional affiliations; the author to whom proofs and correspondence should be addressed should be indicated by an asterisk, and a telephone/fax number and e-mail address included.
Figures should be submitted in triplicate as unmounted glossy prints, suitable for reproduction either across a single column (76 mm) or across a whole page (160 mm); the maximum height is 206 mm. The figures and the lettering should be in proportion and large enough to allow for reduction before printing. All figures should have a legend, typed on a separate page. Reproduction in colour is possible: contact the Managing Editor on how to apply for one of the 30 free colour pages available annually.
Tables should also be typed with double line spacing and have a heading.
References. Only papers using the numbered reference system will be accepted, i.e. references are numbered by order of citation in the text. Journal titles should be abbreviated to conform with Chemical Abstracts Bibliographic Guide for Authors and Editors 1974.
Cost of Colour Reproduction. Reproduction of colour figures in review articles and special issues is free of charge.
Examples:
[1] B.N. Ames, J. McCann, E. Yamasaki, Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test, Mutation Res. 31 (1975) 347-363.
[2] L. Ehrenberg, C.A. Wachtmeister, Safety precautions in work with mutagenic and carcinogenic chemicals, in: B.J. Kilbey, M.S. Legator, W. Nichols and C. Ramel (Eds.), Handbook of Mutagenicity Test Procedures, Elsevier, Amsterdam, 1977, pp. 401-410.
Nomenclature. Authors are requested to adopt the nomenclature system for human gene mutations recommended by the HUGO MDI Nomenclature Working Group. Guidelines for this system can be found at http://journals.wiley.com/1059-7794/nomenclature.html.
USE BACK BUTTON TO RETURN TO THIS PAGE, NOT "Return to Instructions to Authors"
Submission of a manuscript will be held to imply that it contains original work and that it has not been published or submitted for publication elsewhere. It also implies the transfer of the Copyright from the author to the publisher.
Electronic manuscripts have the advantage that there is no need for the rekeying of text, thereby avoiding the possibility of introducing errors and resulting in reliable and fast delivery of proofs. For the initial submission of manuscripts for consideration, hard copies are sufficient. For the processing of accepted papers, electronic versions are required. After final acceptance, your disk plus one final and exactly matching printed version should be submitted together. Please do not split the article into separate files (title page as one file, text as another, etc.). Ensure that the letter `l' and digit `1' (also letter `O' and digit `0') have been used properly, and structure your article (tabs, indents, etc.) consistently. Characters not available on your wordprocessor (Greek letters, mathematical symbols, etc.) should not be left open but indicated by a unique code (e.g., gralpha, @, #, etc., for the Greek letter - ). Such codes should be used consistently throughout the entire text. Please make a list of such codes and provide a key. Do not allow your wordprocessor to introduce word splits and do not use a `justified' layout. Please adhere strictly to the general instructions on style/arrangement and, in particular, the reference style of the journal. It is important that the file saved is in the native format of the wordprocessor program used. Label the disk with the name of the computer and word processing package used, your name, and the name of the file on the disk. After final acceptance, your disk plus one, final, printed and exactly matching version (as a printout) should be submitted together to the accepting editor. It is important that the file on disk and the printout are identical. Both will then be forwarded by the Editor to Elsevier. Further information may be obtained from the Publisher.
Proofs are automatically sent to the corresponding author except for Accelerated Publications and Current Issues which are faxed. Only printer's errors may be corrected, no changes in or additions to the edited manuscript will be accepted. To return corrected proofs by courier service, please send to: Log-in Department, Mutation Research, Elsevier Science B.V., Sara Burgerhartstraat 21, 1055 KV Amsterdam, The Netherlands.

Elsevier will do everything possible to get your article corrected and published as quickly and accurately as possible. Therefore, it is important to ensure that all of your corrections are sent back to us in one communication. Subsequent corrections will not be possible, so please ensure your first sending is complete.

Offprints 25 offprints of each article are sent to the author(s) free of charge. Additional offprints can be ordered by the author(s). Offprint requests after publication will be subject to an extra charge.
Information
All questions arising after acceptance of a manuscript, especially those relating to proofs, publication and reprints, should be directed to the publishers, Martina Canavan at Elsevier Science Ireland Ltd., Elsevier House, Brookvale Plaza, East Park, Shannon, Co. Clare, Ireland; Tel.: +353 61 709610; Email: m.canavan@elsevier.ie
ADDRESSES FOR SUBMISSION OF MANUSCRIPTS All manuscripts except except those from Europe: Prof. E.C. Friedberg, Department of Pathology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-9072, USA, Tel: (1) 214 648 4020, Fax: (1) 214 648 4067, Email: errol.friedberg@utsouthwestern.edu
For manuscripts originating from Europe:
Prof. A. van Zeeland, Department of Radiation Genetics and Chemical Mutagenesis, Leiden University Medical Center, Sylvius Laboratorie, Wassenaarseweg 72, PO Box 9503, 2300 RA Leiden, THE NETHERLANDS, Fax: (31) 71 527 6173, E-mail: ZEELAND@lumc.nl

Guide to Online Submission

Introduction
Welcome to the Elsevier online submission service. This service has been designed to be as easy as possible to use. Authors can upload their article as a LaTeX, Microsoft
® (MS) Word®/I> or WordPerfect®/I>. It is also possible to submit an article in PostScript or Adobe®Acrobat®PDF format, but if the article is accepted it will be necessary to send in the original source files.
The system generates an Adobe Acrobat PDF version of the article which is used for the reviewing process. Authors, Reviewers and Editors send and receive all correspondence by e-mail and no paper correspondence is necessary. Note: articles are converted into PDF for the review process but may be edited after acceptance to follow journal standards.
What to submit?
Journal specific guidelines on types of article accepted and how to prepare your article can be found in the Author Gateway journal page, in the Guide for Authors.
File Formats
Word Processor Formats
Please submit your article as a file in one of the following formats:

  • MS Word 6
  • MS Word 97
  • MS Word 98 for Macintosh®
  • MS Word 2000
  • WordPerfect 6.1 or higher
  • RTF

Important notes on word processor file preparation

  • For review purposes you must submit your article as a SINGLE FILE. You need to embed all your figures and tables within this file.
  • Fonts: Please choose Times, Times New Roman, Courier, Arial or Helvetica fonts as much as possible. Other fonts (e.g. Chinese, Japanese and Korean (CJK) character fonts) may cause the PDF conversion to fail. If your manuscript does not correctly convert to PDF, replace the font(s) where necessary and try again.
  • Most formatting codes will be removed or replaced on processing your article so there is no need for you to apply excessive layout styling. In addition, avoid options such as automatic word breaking, justified layout, double columns, automatic paragraph numbering (especially for numbered references). However, do use bold face, italic, subscripts, superscripts, etc.
  • For the production of your article you will also have to submit your graphic files separately as high resolution graphics. (See also the section on Electronic Artwork below.)

LaTex
For general instructions on how to prepare an article using LaTeX, see the Latex file guidelines. In addition, please note the following:

  • Include all your graphics in the LaTeX file, e.g. with the includegraphics from the graphics package.
  • Submit any special class (or style) files and other macro files with your article. We are using an up-to-date TeX installation (TeXLive5d), so you need not include any of the standard packages.

PDF
If possible, please submit the original LaTeX or word processor files: this website will take care of converting them into a PDF file.
If you wish to create your own PDF, download the ES_review.joboptions to the "Settings" folder of your Acrobat Distiller and choose the "ES_review" joboptions before converting your file.
Note: This joboptions file is for Adobe Distiller v4.05 and later. If you are still working with an older version, or if you need more help, see. PDF settings .
PDF Settings

Where to put the .joboptions file?
Here is how you can find the folder where Adobe Distiller keeps its option files.

 i.          Open Adobe Distiller

ii.          Choose Settings | Job Options...

iii.          Click on Save as...

iv.          The Save in: box shows you the name and the location of the folder where you should save ES_review.joboptions.

v.          Click Cancel twice to leave the Job Options screen.

Distiller version 4
The following screen shots will help you set up your Adobe Distiller for the creation of a usable PDF file. If you are using an older version of Distiller, choose settings as closely as possible to the ones shown in the screenshots.

File naming
To avoid confusion, please make sure your file has a short, descriptive name. Short means less than 30 characters and descriptive means names like figure1.tif and smith-article-version1.doc.
Electronic Artwork
For the production of your paper in the journal we need high-resolution graphic files in either TIFF or EPS. For information on how to prepare your artwork for electronic submission, see http://authors.elsevier.com/artwork.
The online submission process

1.       Find the journal on the Author Gateway by searching or browsing

2.       Read the 'Guide for Authors' for specific instructions on submitting a paper to that journal

3.       Click on the 'online submisssion' link in the right hand journal services box

4.       Log in if you are already a registered user (if you are not already a registered user you need to 'create a profile' by submitting your contact details and choosing a username/password combination). This creates a completely secure environment to send your paper to us online.

5.       Once you are logged in you are taken to the Journal's submission page where you choose to 'Submit New Paper'. You are taken through the following steps:

                         i.            Enter data related to your manuscript (Title, Authors, Keywords etc.)

                        ii.            Choose the accepting Editor. (if the Journal has more than one Editor, you will find a drop-down list with the names of all the Editors of this Journal to whom you may submit your article. The journal Guide for Authors will give you more information on how to decide which Editor to choose)

                      iii.            Upload your manuscript file(s). See the section on File Formats for more information.

                      iv.            The website creates a PDF from your source file(s). You must check this PDF as it will be sent to the reviewers. If the PDF is not OK edit and resubmit your source file(s) or contacts author support for advice - PDF/PostScript source can be submitted as well as LaTeX/Word Processor files.

                       v.            Upload your figures separately for the production process and select how you want your figures to appear in print (colour or black and white). If the figures are too large (>5 Mb) you may send manually direct to the editor.

                      vi.            Check your submission details are correct and press submit to send your files to the journal editor                   

vii.            You will receive an acknowledgement email to say the paper is under review

6.       Until the review process is completed you will not be able to update your submission from the website. If you have made a mistake you must contact the editor.

If revision is required:

1.       You will receive an email from the editor

2.       You can revise your paper by using the link in the email which takes you back to the online submission service (when revising your paper all the previous information is retained - no retyping is needed but it can be updated and new files attached). Alternatively you can access the paper directly from the Journal's online submission page or from 'my home' on the Author Gateway.

3.       Make any changes necessary and add or remove figures/other files

4.       A revised PDF is created which is sent to the editor at the end of the process and you receive an acknowledgement email

5.       Once your new version is submitted you will not be able to make any further revisions from the website

After submission
For information on the status of your article, please contact the Editor to whom you submitted your article. There is an email link to the editor in the journal's online submission service or on 'my home' in the Author Gateway.
Final decision:
You will receive an email containing the final decision of the Editor, containing editorial comments.
After acceptance
Once your paper has been accepted you can track its progress from your home page on the Author Gateway. It will automatically move from the 'Online Submissions' section of 'my home' to 'Accepted Papers'. From here you can view the progress of your paper through the production process to the final published article. We will also email you with the major milestones, including a direct link to your article when it appears on ScienceDirect. For more information on tracking go to Getting Published with Elsevier.
Help
If you have any comments about this document, or any difficulties using this electronic submission site, please contact Author Support at Elsevier.

Author Artwork

Help us to reproduce your artwork to the highest possible standards in both paper and digital formats
Submitting your illustrations, pictures, tables and other artwork in an electronic format helps us to produce your work to the best possible standards, ensuring accuracy, clarity and a high level of detail. This site shows how to prepare your artwork for electronic submission and includes information on common problems, suggestions on how to ensure the best results can be gained plus image creation guides for popular applications. See the links under Application Guidelines for details about using specific artwork software for Windows and Macintosh platforms.

Checklist
Before you send us your artwork, make sure you can answer 'yes' to the following:

My files are in the correct format - TIFF, EPS or MS Office files. See File Formats

My colour images are provided in the RGB colourspace. Note that for a number of Elsevier Health Science journals there is a preference to receive colour images in CMYK, click here to view the list.

The physical dimensions of the artwork match the dimensions of the journal I am submitting to.

The lettering used in the artwork does not vary too much in size. See Sizing of Artwork

I have used the recommended naming conventions. See File Naming

If you are delivering your artwork on disk:

All illustrations are provided as separate files and as hardcopy on separate sheets.

All artwork is numbered according to its sequence in the text.

Figures, schemes and plates have captions and these are provided on a separate sheet along with the manuscript, in addition all figures are referred to in the text.

If required, I have specified the preferred magnification factor of my artwork on the sheet with filenames that accompany the disk.

My artwork is on a 3.5" disk, CD-ROM, ZIP disk or JAZ disk. See Acceptable Media


Editorial Board

 

Editor-in-Chief

E.C. Friedberg, University of Texas Southwestern Medical Center, Department of Pathology, 5323 Harry Hines Boulevard, Dallas, TX 75390-9072, USA

European Receiving Editor:

A.A. van Zeeland, Department of Radiation Genetics and Chemical Mutagenesis, Leiden University Medical Center, Sylvius Laboratories, Wassenaarseweg 72, 2333 AL, Leiden, The Netherlands

Associate Editors

B.A. Bridges, Sussex University, Brighton, United Kingdom
J.H.J. Hoeijmakers, Erasmus University, Rotterdam, The Netherlands
Y. Shiloh, Tel Aviv University Medical School, Tel Aviv, Israel
K. Tanaka, Osaka University, Osaka, Japan
S.H. Wilson, National Institute of Health, Research Triangle Park, North Caroline, USA
R.D. Wood, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA

Editorial Board:

D.F. Bogenhaugen, SUNY, Stony Brook, NY, U.S.A.
V.A. Bohr, National Institutes on Aging, Baltimore, MD, U.S.A.
S. Boiteux, Commissariat Energie Atomique (CEA), Fontenay Aux Roses, France
J. Brouwer, Leiden University, Leiden, The Netherlands
K.W. Caldecott, University of Sussex, Brighton, United Kingdom
A.M. Carr, Sussex University, Brighton, United Kingdom
P.K. Cooper, Lawrence Berkeley National Lab, Berkeley, CA, U.S.A.
B. Demple, Harvard School of Public Health, Boston, MA, USA
G.L. Dianov, MRC Radiation and Genome Stability Unit, Oxfordshire, United Kingdom
E. Dogliotti, Istituto Superiore di Sanita', Rome, Italy
J-M. Egly, I.G.B.M.C., Illkirch, France
J.M. Essigman, MIT, Cambridge, MA, U.S.A.
R. Fishel, Kimmel Cancer Center, Philadelphia, PA, U.S.A.
A.J. Fornace, National Cancer Institute, Bethesda, MD, USA
R.P.P. Fuchs, CNRS - ESBS, Strasbourg, France
A. Ganesan, Stanford University, Stanford, CA, U.S.A.
J. Gautier, Columbia University, New York, NY, USA
M.F. Goodman, University of South California, Los Angeles, CA, U.S.A.
N. Goosen, Leiden Institute of Chemistry, Leiden, The Netherlands
A.P. Grollman, SUNY at Stony Brook, Stony Brook, New York
T. Halazonetis, Wistar Insitute, Philadelphia, Pennsylvania
F. Hanaoka, Osaka University, Japan
P.C. Hanawalt, Stanford University, Stanford, California
I.D. Hickson, Imperial Cancer Research Fund, United Kingdom
P.H. Hsieh, National Institutes of Health, Bethesda, Maryland
S.P. Jackson, Wellcome/CRC Instute, United Kingdom
P.A. Jeggo, Sussex University, United Kingdom
S. Jink-Robertson, Emory University, Atlanta, Georgia
B. Kaina, University of Mainz, Mainz, Germany
R. Kanaar, Erasmus University, The Netherlands
P.B Karran, Imperial Cancer Research Fund, United Kingdom
C. Kisker, Suny-Stony Brook, Stony Brook, NY, U.S.A.
H. Klein, NYU Medical Center, New York, NY, USA
R. Kolodner, Ludwig Institute for Cancer Research, La Jolla, CA, USA
H.E. Krokan, University of Trondheim, Trondheim, Norway
T.A. Kunkel, NIEHS, NIH, Research Triangle Park, NC, U.S.A.
J. Laval, Institut Gustave Roussy, Villejuif Cedex, France
C.W. Lawrence, University of Rochester, Rochester, NY, U.S.A.
R. Legerski, UT MD Anderson Cancer Center, Houston, TX, USA
A.R. Lehmann, University of Sussex, Brighton, United Kingdom
M.R. Lieber, University of Southern California, Los Angeles, CA, USA
T. Lindahl, ICRF Clare Hall Laboratories, South Mimms, United Kingdom
S. Linn, University of California, Berkeley, CA, USA
M. Liskay, Oregon Health Science University, Portland, U.S.A.
Z. Livneh, The Weizmann Institute of Science, Rehovot, Israel
L.A. Loeb, University of Washington, Seattle, WA, USA
V.M. Maher, Carcinogenesis Laboratory, East Lansing, MI, USA
I. Mellon, University of Kentucky, Lexington, KY, U.S.A.
J.H. Miller, UCLA - MIMG, Los Angeles, CA, USA
P.L. Modrich, Duke University Medical Center, Durham, NC, USA
D.W. Mosbaugh, Oregon State University, Corvallis, OR, USA
L.H.F. Mullenders, Leiden University, Leiden, The Netherlands
G. Murcia
de, Ecole Superieure de Biotechnologie de Strasbourg, Illkirch-Graffenstaden, France
H. Naegeli, Institute of Pharmacology and Toxicology, Zurich, Zwitzerland
Y. Nakabeppu, Kyushu University, Fukuoka, Japan
T. Nohmi, Division of Genetics and Mutagenesis, National Institute of Health Sciences, Tokyo, Japan
V.R. Otrin, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA
T.D. Petes, University of North Carolina, Chapel Hill, NC, U.S.A.
J.H.J. Petrini, University of Wisconsin, Madison, WI, U.S.A.
M. Radman, University of Paris-5, Paris, France
M.A. Resnick, National Iinstitute of Environmental Health Sciences, Research Triangle Park, NC, USA
S.M. Rosenberg, One Baylor College, USA
R. Rothstein, Columbia University, New York, NY, USA
L. Samson, Massachusetts Institute of Technology, Cambridge, Massachusetts
A.R. Sarasin, CNRS, Villejuif, France
R.A. Schultz, The University of Texas Southwestern, Dallas, TX, U.S.A.
E. Seeberg, The Norwegian State Hospital, Oslo, Norway
M. Sekiguchi, Dukuoka Dental College, Fukuoka, Japan
H. Shinagawa, Osaka University, Osaka, Japan
M. Stefanini, Instituto di Genetica Biochimica, Pavia, Italy
P. Sung, University of Texas, San Antonio, TX, U.S.A.
J. Svejstrup, Clare Hall Laboratories, South Mimms, United Kingdom
J. Tainer, Scripps Research Institute, La Jolla, CA, U.S.A.
J. Thacker, Radiation and Genome Stability Unit, Harwell, United Kingdom
F. Thoma, Institut fur Zellbiologie, Zurich, Switzerland
L.H. Thompson, Lawrence Livermore National Laboratory, Livermore, CA, U.S.A.
A. Tomkinson, UTHSC, San Antonio, TX, U.S.A.
B. Van Houten, DERT, NIEHS, Research Triangle Park, NC, U.S.A.

 



 返回页首 


邮编:430072   地址:中国武汉珞珈山   电话:027-87682740   管理员Email:
Copyright © 2005-2006 武汉大学图书馆版权所有